Saturday 27 September

18:30 - 20:00
Coworking Space

Open Innovation finalists live pitch

Health Without Borders: Solving the Unsolved

Challenges Partners Medtronic Hellas & CardioSchool | Bayer Greece

Organised by EDIH Health Hub and JOIST Innovation Park, the Open Innovation Challenge 2025 is a flagship part of InnoHealth Forum 2025—the leading conference and expo on medtech, pharma, and digital health in Southeast Europe.

This year, we’re calling on startups, researchers, and interdisciplinary teams to submit market-ready or near-ready innovations that tackle the biggest unsolved challenges in healthcare. Finalists will be selected to pitch live at InnoHealth 2025, in front of a jury of investors, corporates, clinicians, and public sector leaders.

Structure

  • Pre-event call for solutions in selected themes
  • Selection of 8 finalists to pitch live at the event
  • Jury: mix of VCs, corporates, public institutions
  • Prizes: to be announced

2025 Focus Areas

We welcome challenges to be met across the following pillars:

A. Early detection and intervention of atrial fibrillation (AF) and associated stroke risk factors.

| By Medtronic Hellas & CardioSchool

Objectives

  1. Early Detection: Develop advanced diagnostic tools and techniques to identify atrial fibrillation at its earliest stages, even in asymptomatic patients.
  2. Risk Stratification: Create innovative methods to assess and stratify patients based on their risk factors for stroke, ensuring timely and targeted interventions.
  3. Intervention Strategies: Design and implement effective intervention strategies to manage atrial fibrillation and mitigate the risk of stroke.
  4. Patient Monitoring & Empowerment: Develop continuous monitoring solutions to track patient health and detect any changes in their condition in real-time, combined with solutions that improve patients’ health literacy and self-care level.
  5. Data Integration: Utilize big data and artificial intelligence to integrate patient data from various sources, providing a comprehensive view of patient health and facilitating personalized treatment plans.

B. Oncology, Prostate cancer

| By Bayer Greece

Prostate cancer is the second most frequently diagnosed malignancy among men worldwide and the fifth leading cause of cancer-related death in this population. The number of prostate cancer diagnoses is increasing, possibly due to the overall rise in life expectancy. At Bayer, we strive to improve outcomes and make a difference for men who are at risk of or have been diagnosed early with prostate cancer.

Objectives

We are seeking digital solutions that embrace cutting-edge technology for the comprehensive care and management of patients, with a particular interest in remote monitoring / self-monitoring for Prostate-Specific Antigen (PSA).

Challenge Details

Eligibility

  • Startups (MVP stage and beyond)
  • University spin-offs
  • Research teams with commercialization potential
  • SMEs with an innovation angle
  • Healthcare professionals

Key Dates

  • Applications Open: mid-July 2025
  • Deadline to Apply: 10 September 2025
  • Finalists Announced: 15 September 2025
  • Live Pitch at InnoHealth: 26–27 September 2025

Applications

Proposals submitted by working groups should be submitted in pptx (PowerPoint) format, with a maximum of 12 slides. In addition, proposals may be accompanied by clarifications – annotations in Word text, up to 500 words.

The proposals of the working groups should include the following sections:

  • Identification of need / definition of a need-based framework for action (3 slides)
  • Existing solutions (1 slide)
  • Proposal to the challenge (2-3 slides)
  • Budget – Budget (1 slide)
  • The working group (1 slide) (2-3 slides)
  • Expected results – Risk analysis (1-2 slides)

Teams participating in the Open Innovation Challenge can consist of two (2) to five (5) people. Only natural persons aged 18 years or older are eligible to participate in the teams. The maximum number of teams participating in final phase of the Open Innovation is eight (8). In the event of entries exceeding the maximum number, the selected proposals will be evaluated by the competent committee on the basis of the evaluation criteria set out below, which will be used for the final ranking.

Criteria against which proposals will be evaluated

  • The characteristics of the working group.
  • The maturity of the proposal.
  • The relevance of the proposal in relation to the challenge.
  • The realism of the proposal (as a whole) and its constituent parts (objectives, budget, expected results).

At the end of the evaluation, prizes will be awarded to the top three proposals in the overall score.

Prizes

To be announced.

Application Form

Fill in the form below to submit your application for the Open Innovation Challenge 2025, part of InnoHealth Forum.

Media Kit

Download and use the banners to promote your participation in InnoHealth Forum 2025 on your social media and digital channels.